Clovis Oncology Inc (NASDAQ:CLVS)

82.09
Delayed Data
As of May 01
 +1.73 / +2.15%
Today’s Change
35.33
Today|||52-Week Range
94.88
+46.59%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 100.00, with a high estimate of 117.00 and a low estimate of 85.00. The median estimate represents a +21.82% increase from the last price of 82.09.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.73
Sales
$0.00
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.61%
 
 
 
 
 
 
Growthannually -72.42%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -85.07%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account